In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells

Published:2016-02 Issue:3 Volume:26 Page:1073-1079
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Byun Joon Seok,Sohn Joo Mi,Leem Dong Gyu,Park Byeongyeon,Nam Ji Hye,Shin Dong Hyun,Shin Ji Sun,Kim Hyoung Ja,Lee Kyung-Tae,Lee Jae Yeol

Funder

Ministry of Education

New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference36 articles.

2. Epidemiology: The dominant malignancy

3. US National Cancer Institute, Surveillance, Epidemiology, and End Results Program Cancer Statistics Review 1975–2011.

4. A therapeutic area review of oncology products and players

5. Challenging the platinum combinations in the chemotherapy of NSCLC

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-small cell lung cancer sensitisation to platinum chemotherapy via new thiazole-triazole hybrids acting as dual T-type CCB/MMP-9 inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-08-14

2. OZ-001 suppresses the growth of triple-negative breast cancer and pancreatic cancer via targeting STAT3 phosphorylation and calcium signaling pathway;2024-08-08

3. De novo Synthesis of Chiral 3,4‐DihydroquinazolinesviaOne‐Pot Enantioselective Ugi‐Azide/Cyclization Sequences^†;Chinese Journal of Chemistry;2024-05-07

4. One-Pot Reductive Amination/N-Acylation/Aza-Wittig Reaction for the Synthesis of 3,4-Dihydroquinazolines;Chinese Journal of Organic Chemistry;2024

5. Ion channels in lung cancer: biological and clinical relevance;Frontiers in Pharmacology;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3